The 2023 Annual Congress of the EACR 2023 is a four-day congress dedicated to basic, preclinical, and translational cancer research across a wide breadth of topics. It will highlight the latest research and bring together the cancer research community to inspire innovation and build knowledge, connections, and collaborations. The delegate population will thus simulate the multidisciplinary teams that act in the real world to facilitate interdisciplinary research and patient treatment and care.
The Congress will include various symposia and educational lectures, meet-the-expert workshops, keynote lectures from a range of renowned names in cancer research, and career discovery sessions dedicated to young researchers new to the field.
Speakers: Nicola Aceto (Switzerland), Julio Aguirre-Ghiso (USA), Raza Ali (UK), Chiara Ambrogio (Italy), Allan Balmain (USA), Mariano Barbacid (Spain), Roderick Beijersbergen (Netherlands), Carlos Caldas (UK), Peter Campbell (UK), Arkaitz Carracedo (Spain), Chiara Maria Cattaneo (Italy), Roberto Chiarle (Italy), Francesca Ciccarelli (UK), Direna Alonso Curbelo (Spain), Mark Dawson (USA), Johann de Bono (UK), Martin Eilers (Germany), John Haanen (Netherlands), Simon Haas (Germany), Doug Hannahan (Switzerland), Johanna A. Joyce (Switzerland), Christoph Klein (Germany), Marleen Kok (Netherlands), Evi Lianidou (Greece), Nuria Lopez-Bigas (Spain), Shiva Malek (Switzerland), Elaine R. Mardis (USA), Silvia Marsoni (Italy), Ingio Martincorena (UK), Joaquin Mateo (Spain), Cristina Mayor-Ruiz (Spain), Massimiliano Mazzone (Belgium), Rene Medema (Netherlands), Sandra Misale (USA), Luigi Naldini (Italy), Anna Obenauf (Austria), Johanna Olweus (Norway), Yaara Oren (USA), Massimiliano Pagani (Italy), Ruth Palmer (Sweden), Ronald Plasterk (Netherlands), Steve Pollard (UK), Nikolaus Rajewsky (Germany), Raphael Rodriguez (France), Mariangela Russo (Italy), Yardena Samuels (Israel), Nicola Segata (Italy), Marisol Soengas (Spain), Ravid Straussman (Israel), Mario Suva (USA), Nicola Ternette (USA), Andrea Viale (USA), Rinse Weersma (Netherlands), Jukka Westermarck (Finland), George E. Winter (Austria), and Mariia Yuneva (UK)
Keywords: advanced T-cell therapies, cell competition, challenging drug targets, chemical biology, computational biology and AI, drug resistance, drugging the RAS pathway, microbiome and immune system interface, liquid biopsies, mechanism-based clinical trials, model organisms, neoantigens and vaccines, biology of early cancer, spatial transcriptomics, tumor metabolism, epigenetic control, tumor dormancy, tumor persistence, tumor ecology at single-cell level, tumor evolution, oncology
The Congress will include various symposia and educational lectures, meet-the-expert workshops, keynote lectures from a range of renowned names in cancer research, and career discovery sessions dedicated to young researchers new to the field.
Speakers: Nicola Aceto (Switzerland), Julio Aguirre-Ghiso (USA), Raza Ali (UK), Chiara Ambrogio (Italy), Allan Balmain (USA), Mariano Barbacid (Spain), Roderick Beijersbergen (Netherlands), Carlos Caldas (UK), Peter Campbell (UK), Arkaitz Carracedo (Spain), Chiara Maria Cattaneo (Italy), Roberto Chiarle (Italy), Francesca Ciccarelli (UK), Direna Alonso Curbelo (Spain), Mark Dawson (USA), Johann de Bono (UK), Martin Eilers (Germany), John Haanen (Netherlands), Simon Haas (Germany), Doug Hannahan (Switzerland), Johanna A. Joyce (Switzerland), Christoph Klein (Germany), Marleen Kok (Netherlands), Evi Lianidou (Greece), Nuria Lopez-Bigas (Spain), Shiva Malek (Switzerland), Elaine R. Mardis (USA), Silvia Marsoni (Italy), Ingio Martincorena (UK), Joaquin Mateo (Spain), Cristina Mayor-Ruiz (Spain), Massimiliano Mazzone (Belgium), Rene Medema (Netherlands), Sandra Misale (USA), Luigi Naldini (Italy), Anna Obenauf (Austria), Johanna Olweus (Norway), Yaara Oren (USA), Massimiliano Pagani (Italy), Ruth Palmer (Sweden), Ronald Plasterk (Netherlands), Steve Pollard (UK), Nikolaus Rajewsky (Germany), Raphael Rodriguez (France), Mariangela Russo (Italy), Yardena Samuels (Israel), Nicola Segata (Italy), Marisol Soengas (Spain), Ravid Straussman (Israel), Mario Suva (USA), Nicola Ternette (USA), Andrea Viale (USA), Rinse Weersma (Netherlands), Jukka Westermarck (Finland), George E. Winter (Austria), and Mariia Yuneva (UK)
Keywords: advanced T-cell therapies, cell competition, challenging drug targets, chemical biology, computational biology and AI, drug resistance, drugging the RAS pathway, microbiome and immune system interface, liquid biopsies, mechanism-based clinical trials, model organisms, neoantigens and vaccines, biology of early cancer, spatial transcriptomics, tumor metabolism, epigenetic control, tumor dormancy, tumor persistence, tumor ecology at single-cell level, tumor evolution, oncology
